Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 28 M18 M9 M18 M35 M24 M 86 M Research & development —————— — Operating income 295 M308 M434 M132 M350 M158 M 1.07 B Non-Operating Income, Total 526 M543 M582 M557 M525 M555 M 2.22 B Interest expense, net of interest capitalized 67 M63 M60 M146 M61 M68 M 335 M Non-Operating Income, excl. Interest Expenses 459 M480 M522 M411 M464 M487 M 1.88 B Unusual income/expense —————— — Pretax income 173 M188 M307 M169 M230 M34 M 740 M Equity in earnings —————— — Taxes 22 M27 M35 M20 M35 M16 M 106 M Non-controlling/minority interest -5 M-5 M80 M9 M13 M-76 M 26 M After tax other income/expense —————— — Net income before discontinued operations 156 M166 M192 M140 M182 M94 M 608 M Discontinued operations —————— — Net income 156 M166 M192 M140 M182 M94 M 608 M Dilution adjustment 000000 0 Preferred dividends 17 M4 M16 M4 M17 M4 M 41 M Diluted net income available to common stockholders 139 M162 M176 M136 M165 M90 M 567 M Basic earnings per share (Basic EPS) 1.451.691.821.441.780.99 6.03 Diluted earnings per share (Diluted EPS) 1.421.661.81.411.750.97 5.93 Average basic shares outstanding 95.9 M96.4 M95.9 M95.8 M93.1 M90.8 M — Diluted shares outstanding 97.8 M97.7 M97.4 M97.4 M94.5 M92.3 M — EBITDA 335 M373 M525 M402 M393 M231 M 1.55 B EBIT 295 M308 M434 M132 M350 M158 M 1.07 B Cost of revenue 850 M816 M865 M1.04 B833 M840 M 3.58 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 40 M65 M91 M270 M43 M73 M 477 M